Endoscopic Submucosal Dissection Registry

Last updated: November 9, 2024
Sponsor: Carol Davila University of Medicine and Pharmacy
Overall Status: Active - Recruiting

Phase

N/A

Condition

Digestive System Neoplasms

Stomach Cancer

Neoplasms

Treatment

Endoscopic submucosal dissection (ESD)

Clinical Study ID

NCT06033976
ESDREG
  • Ages 18-100
  • All Genders

Study Summary

This is a patient registry for all cases of pre-neoplastic or early neoplastic digestive tract lesions treated with curative intention by endoscopic submucosal dissection (ESD) technique.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • epithelial pre-neoplastic (eg. adenoma, dysplasia) lesion on the esophageal,gastric, duodenal or colorectal mucosa

  • non-epithelial (eg. neuroendocrine tumor) lesion on the esophageal, gastric,duodenal or colorectal mucosa

  • age > 18 years old

  • informed consent

Exclusion

Exclusion Criteria:

  • age < 18 years old

  • no informed consent

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Endoscopic submucosal dissection (ESD)
Phase:
Study Start date:
January 01, 2021
Estimated Completion Date:
January 31, 2031

Study Description

Cases will be registered one by one in an electronic record, with the consent of the patient and respecting all legal requirements.

Connect with a study center

  • "Agrippa Ionescu" Hospital

    Bucharest,
    Romania

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.